Vanda Pharmaceuticals Inc. (FRA:VM4)
4.540
0.00 (0.00%)
Last updated: Dec 1, 2025, 8:19 AM CET
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 368 employees as of December 31, 2024. The number of employees increased by 165 or 81.28% compared to the previous year.
Employees
368
Change (1Y)
165
Growth (1Y)
81.28%
Revenue / Employee
€491,170
Profits / Employee
€195,008
Market Cap
255.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 368 | 165 | 81.28% |
| Dec 31, 2023 | 203 | -87 | -30.00% |
| Dec 31, 2022 | 290 | 12 | 4.32% |
| Dec 31, 2021 | 278 | -14 | -4.79% |
| Dec 31, 2020 | 292 | 8 | 2.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Vanda Pharmaceuticals News
- 20 hours ago - Vanda Pharma Extends FDA Re Review Timeline For Tradipitant Clinical Hold To December 5 - Nasdaq
- 1 day ago - Should You Invest in This Under-the-Radar Weight Loss Stock? - The Motley Fool
- 3 days ago - FDA Extends Review of Vanda Pharmaceuticals' (VNDA) Tradipitant - GuruFocus
- 3 days ago - FDA Fast-Tracks Vanda's Motion Sickness Drug Review After Leadership Shake-Up - Benzinga
- 3 days ago - Vanda Pharmaceuticals Announces Updated FDA Timeline For Tradipitant - Nasdaq
- 3 days ago - Vanda Pharmaceuticals (VNDA) Updates on Tradipitant for Motion Sickness - GuruFocus
- 3 days ago - Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness - PRNewsWire
- 10 days ago - Vanda Pharmaceuticals: Commercial Execution Meets Pipeline Optionality - Seeking Alpha